Morin PJ - Search Results

1

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.

Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M, Wang GM, Jelovac D, Weeraratna A, Sherman Baust CA, Morin PJ, Toubaji A, Meeker A, De Marzo AM, Lewis G, Subhawong A, Argani P, Park BH. Garay JP, et al. Among authors: morin pj. Breast Cancer Res. 2012 Feb 9;14(1):R27. doi: 10.1186/bcr3112. Breast Cancer Res. 2012. PMID: 22321971 Free PMC article.

2

Wnt signaling in human cancer.

Morin PJ, Weeraratna AT. Morin PJ, et al. Cancer Treat Res. 2003;115:169-87. doi: 10.1007/0-306-48158-8_7. Cancer Treat Res. 2003. PMID: 12613197 Review. No abstract available.

3

Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.

Sawiris GP, Sherman-Baust CA, Becker KG, Cheadle C, Teichberg D, Morin PJ. Sawiris GP, et al. Among authors: morin pj. Cancer Res. 2002 May 15;62(10):2923-8. Cancer Res. 2002. PMID: 12019173

4

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

Sherman-Baust CA, Weeraratna AT, Rangel LB, Pizer ES, Cho KR, Schwartz DR, Shock T, Morin PJ. Sherman-Baust CA, et al. Among authors: morin pj. Cancer Cell. 2003 Apr;3(4):377-86. doi: 10.1016/s1535-6108(03)00058-8. Cancer Cell. 2003. PMID: 12726863 Free article.

5

Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer.

Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ. Li J, et al. Among authors: morin pj. BMC Cancer. 2009 Jul 20;9:244. doi: 10.1186/1471-2407-9-244. BMC Cancer. 2009. PMID: 19619303 Free PMC article.

6

The APC tumor suppressor pathway.

Morin PJ, Weeraratna AT. Morin PJ, et al. Methods Mol Biol. 2003;222:21-40. doi: 10.1385/1-59259-328-3:021. Methods Mol Biol. 2003. PMID: 12710678 No abstract available.

7

Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.

Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ. Hough CD, et al. Among authors: morin pj. Cancer Res. 2000 Nov 15;60(22):6281-7. Cancer Res. 2000. PMID: 11103784

8

Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression.

Rangel LB, Sherman-Baust CA, Wernyj RP, Schwartz DR, Cho KR, Morin PJ. Rangel LB, et al. Among authors: morin pj. Oncogene. 2003 Oct 16;22(46):7225-32. doi: 10.1038/sj.onc.1207008. Oncogene. 2003. PMID: 14562052

9

MicroRNA expression and identification of putative miRNA targets in ovarian cancer.

Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood W 3rd, Becker KG, Morin PJ. Dahiya N, et al. Among authors: morin pj. PLoS One. 2008 Jun 18;3(6):e2436. doi: 10.1371/journal.pone.0002436. PLoS One. 2008. PMID: 18560586 Free PMC article.

10

Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin.

Sherman-Baust CA, Becker KG, Wood Iii WH, Zhang Y, Morin PJ. Sherman-Baust CA, et al. Among authors: morin pj. J Ovarian Res. 2011 Dec 5;4(1):21. doi: 10.1186/1757-2215-4-21. J Ovarian Res. 2011. PMID: 22141344 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters